Zapping pancreatic tumors with heat: a Needle-Sized hope
NCT ID NCT07585032
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a procedure called EUS-guided radiofrequency ablation (EUS-RFA) for people with pancreatic insulinoma, a rare tumor that causes low blood sugar. The procedure uses a thin needle passed through an endoscope to deliver heat and destroy the tumor. Researchers want to see if it is safe and effective at relieving symptoms, with the goal of offering a less invasive alternative to surgery. The trial is currently recruiting 20 participants in Sweden.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EUS-guided radiofrequency ablation (EUS-RFA)
- What this could lead to
- If it works, this could offer a less invasive treatment option for pancreatic insulinoma, potentially reducing symptoms and avoiding major surgery.
- What could go wrong
- This is a small, early-phase trial with only 20 participants. The procedure may not fully destroy the tumor, and there are risks like bleeding, infection, or pancreatitis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULINOMA; PANCREAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sahlgrenska Univeristy Hospital
RECRUITINGGothenburg, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.